Division of Critical Care Medicine, Montefiore Medical Center, Bronx, NY.
Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
Crit Care Explor. 2024 Nov 21;6(12):e1181. doi: 10.1097/CCE.0000000000001181. eCollection 2024 Dec 1.
"Awake" cannulation for venovenous extracorporeal membrane oxygenation (ECMO), where patients remain spontaneously breathing without invasive mechanical ventilation during the cannulation procedure, may reduce lung injury from positive pressure ventilation and promote patient mobility.
To examine the association between "awake" cannulation for venovenous ECMO and patient outcomes.
DESIGN, SETTING, AND PARTICIPANTS: Analysis of the prospectively collected by the multicenter Extracorporeal Life Support Organization registry. Patients 18 years old or older who were cannulated for venovenous ECMO between 2016 and 2022 were included.
Propensity score matching techniques were used to examine the association between the primary exposure of "awake" cannulation and the primary outcome of hospital mortality.
This study analyzed data from 28,627 patients who received venovenous ECMO, including 797 (2.8%) who underwent awake cannulation. Patients undergoing awake cannulation were older (52.2 vs. 47.8 yr), had greater prevalence of chronic lung diseases (50.6% vs. 48.9%), and ischemic heart disease (4.3% vs. 2.7%) compared with those cannulated while receiving mechanical ventilation. Hospital survival to discharge was did not differ significantly between awake and nonawake cannulation groups after propensity score matching (2.4% increased rate of survival for patients cannulated awake; 95% CI, -1.7% to 6.4%; p = 0.26).
In this large, multicenter study, awake cannulation for venovenous ECMO was uncommon but increasingly used over time. Survival to hospital discharge was similar to patients cannulated while on mechanical ventilation. Future research should focus on identification of patient cohorts most likely to benefit from ""awake" cannulation.
“清醒”插管用于静脉-静脉体外膜肺氧合(ECMO),在此过程中患者在插管过程中保持自主呼吸而不接受有创机械通气,这可能会减少正压通气引起的肺损伤,并促进患者的活动能力。
检查静脉-静脉 ECMO 清醒插管与患者结局之间的关联。
设计、设置和参与者:对多中心体外生命支持组织注册处前瞻性收集的数据进行分析。纳入 2016 年至 2022 年期间接受静脉-静脉 ECMO 插管的年龄在 18 岁或以上的患者。
使用倾向评分匹配技术来检查主要暴露因素“清醒”插管与主要结局院内死亡率之间的关联。
这项研究分析了 28627 名接受静脉-静脉 ECMO 治疗的患者的数据,其中 797 名(2.8%)接受了清醒插管。与接受机械通气时插管的患者相比,接受清醒插管的患者年龄更大(52.2 岁 vs. 47.8 岁),患有慢性肺部疾病的比例更高(50.6% vs. 48.9%),以及缺血性心脏病(4.3% vs. 2.7%)。在进行倾向评分匹配后,清醒和非清醒插管组的院内存活至出院率没有显著差异(清醒插管患者的存活率增加了 2.4%;95%CI,-1.7%至 6.4%;p=0.26)。
在这项大型多中心研究中,静脉-静脉 ECMO 的清醒插管并不常见,但随着时间的推移使用逐渐增加。出院时的存活率与接受机械通气时插管的患者相似。未来的研究应集中于确定最有可能从“清醒”插管中获益的患者群体。